TipRanks
Advertisement
Advertisement
Protagenic announces two engagements to support advancement of PT00114
PremiumThe FlyProtagenic announces two engagements to support advancement of PT00114
4M ago
Protagenic Therapeutics appoints Nichols Jr. as President
Premium
The Fly
Protagenic Therapeutics appoints Nichols Jr. as President
5M ago
Protagenic Therapeutics Announces Termination of Chief Financial Officer
Premium
Company Announcements
Protagenic Therapeutics Announces Termination of Chief Financial Officer
6M ago
Protagenic Therapeutics announces delay in quarterly filing
PremiumCompany AnnouncementsProtagenic Therapeutics announces delay in quarterly filing
7M ago
Protagenic Therapeutics Prepares for Nasdaq Delisting, OTC Trading
Premium
Company Announcements
Protagenic Therapeutics Prepares for Nasdaq Delisting, OTC Trading
9M ago
Protagenic reports results from Phase 1 multiple-dose study of PT00114
Premium
The Fly
Protagenic reports results from Phase 1 multiple-dose study of PT00114
10M ago
Protagenic Therapeutics Seeks Rescission of Share Agreement
PremiumCompany AnnouncementsProtagenic Therapeutics Seeks Rescission of Share Agreement
11M ago
Protagenic Therapeutics Faces Nasdaq Compliance Notice
Premium
Company Announcements
Protagenic Therapeutics Faces Nasdaq Compliance Notice
1y ago
Protagenic advances PT00114 into multiple-dose Phase 1 trial
Premium
The Fly
Protagenic advances PT00114 into multiple-dose Phase 1 trial
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100